封面图片
2022年, 第16卷 第5期
Inhibition of GNAQ/11 palmitoylation inhibits GNAQ/11 oncogenic transformation by interfering with the MAPK pathway and BCL2 survival pathway in GNAQ/11-mutant uveal melanoma cells and exhibits a synergistic effect with the BCL2 inhibitor in the treatment of GNAQ/11-mutant uveal melanoma. (Courtesy of Drs. Bo Jiao and Ruibao Ren. See pages 784-798 by Yan Zhang et al. for more information.)